Biotech company Oxford Nanopore Technologies has announced a £109.5 million investment through new capital and a secondary sale of shares. The British business develops a portable DNA/RNA sequencer that provides real-time biological data analysis. The deal brings Oxford Nanopore's total primary investment to around £480 million.